Astellas Pharma

www.astellas.com

2-3-11 Nihonbashi-Honcho
Chuo-Ku
Tokyo
103-8411
Japan

+81 3 3244 3000

Activities

Pharmaceutical

Related Content

Astella invests $3.5m in antibody drug facility
Astella invests $3.5m in antibody drug facility
Therapeutic: zolbetuximab for gastric cancer
Therapeutic: zolbetuximab for gastric cancer
Astellas acquires mitochondrial specialist for $15m
Astellas acquires mitochondrial specialist for $15m
Astellas invests $13m in cell and gene therapy innovation incubators
Astellas invests $13m in cell and gene therapy innovation incubators
Astellas names Rodrigo Fernandez as Executive Director, International Business
Astellas names Rodrigo Fernandez as Executive Director, International Business
New President of EMEA Operations for Astellas
New President of EMEA Operations for Astellas
Astellas promotes Catherine Wertjes to Head of Ethics & Compliance
Astellas promotes Catherine Wertjes to Head of Ethics & Compliance
Astellas names James Robinson as President, Americas Operations
Astellas names James Robinson as President, Americas Operations
Astellas transfers its global dermatology business to LEO Pharma
Astellas transfers its global dermatology business to LEO Pharma
Astellas to buy Ocata Therapeutics
Astellas to buy Ocata Therapeutics
Astellas and Anokion to collaborate on immune tolerance therapeutics
Astellas and Anokion to collaborate on immune tolerance therapeutics
Astellas and Potenza link up to build a portfolio of immuno-oncology therapeutics
Astellas and Potenza link up to build a portfolio of immuno-oncology therapeutics
Syntheses that cut costs and boost yields
Syntheses that cut costs and boost yields
Cancer Research UK to work with Astellas to find new cancer treatments
Cancer Research UK to work with Astellas to find new cancer treatments
Antifungal agent – isavuconazole
Antifungal agent – isavuconazole